维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="Hehlmann"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Drug treatmen tissu pefiorto all ograftingas first - linetherapyin chronic myel old leukemia 显示文摘	Hehlmann R BergerU PfirrmannM etal	2007	Blood2007，109，11：	1
2	Chronic myeloid leukaemia显示文摘	Hehlmann R Hochhaus A Baccarani M	2007	Lancet2007，370，：	1
3	Early molecular and cytogenetic response is predictive for long-term progression- free and overall survival in chronic myeloid leukemia (CML)显示文摘	Hanfstein B Mfiller MC Hehlmann R	2012	Leukemia2012，26，9：	1
4	Chronic myeloid leukaemia显示文摘	Rüdiger Hehlmann Andreas Hochhaus Michele Baccarani	2007	2007 (9584)2007，，9584：	1
5	Application of Thermal Analysis in a Phase Composition Study on By-product from Semi-dry Flue Gas Desulfurization System显示文摘	Zaremba T Dukowicz A Hehlmann J		0，，74：	1
6	Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia显示文摘	Hehlmann R Berger U Pfirrmann M		Blood0，，：	1
7	DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients显示文摘	Spiess B Seifarth W Hummel M Frank O Fabarius A Zheng C Morz H Hehlmann R Buchheidt D	2007	J Clin Microbiol2007，45，11：	1
8	Drug treatment is superior to allogvafting as first-line therapy in chronic myeloid leukemia显示文摘	Hehlmann R Berger U Pfirrmann M	2007	Blood2007，109，11：	1
9	Chronic myeloid leukaemia显示文摘	Hehlmann R Hochhous A Baccarani M	2007	Lancet2007，370，9584：	1
10	Chronic myeloid leukaemia显示文摘	Hehlmann R Hochhaus A Baccarani M	2007	The Lancet2007，370，9584：	1
11	Aneuploidy, the primary cause of the multilateral gcnomic instability of neoplastic and preneoplastic cells显示文摘	Duesberg P Fabarius A Hehlmann R	2004	IUBMB Life2004，56，2：	1
12	Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia显示文摘	Hehlmann R Berger U Pfirrmann M	2007	Blood2007，109，11：	1
13	Chronic myeloid leukaemia显示文摘	HEHLMANN R HOCHHAUS A BACCARANI M	2007	Lancet2007，370，9584：	1
14	Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia(CML)显示文摘	HANFSTEIN B MLLER MC HEHLMANN R	2012	Leukemia2012，26，9：	1
15	Interferon-a before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely provided it is discontinued at least 90 days before the procedure显示文摘	Hehlmann R Hochhaus A Kolb H J	1999	Blood1999，94，：	1
16	Chronic myeloid leukaemia显示文摘	Hehlmann R Hochhaus A Baccarani M	2007	Lancet2007，370，9584：	1
17	Reemergence of interferon-alpha in the treatment of chronic myeloid leukemia显示文摘	Talpaz M Hehlmann R Quintas-Cardama A	2013	Leukemia2013，27，4：	1
18	Randomized comparison of interferon α with busulfan and hydroxyurea in chronic myelogenous leukemia显示文摘	Hehlmann R Heimpel H Hasfold J	1994	Blood1994，84，：	1
19	Interferon-a before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely provided it is discontinued at least 90 days before the procedure显示文摘	Hehlmann R Hochhaus A Kolb H J	1999	Blood1999，94，：	1
20	Current,CML,therapy progresse and dilemma显示文摘	Hehlmann R	2003	Leukemia2003，17，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示